相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells
Tilman D. Rachner et al.
CANCER LETTERS (2010)
Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study
M. Etminan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Andrew J. Wiemer et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases
In Hae Park et al.
BMC CANCER (2009)
Osteoporosis treatments and adverse events
Daniel H. Solomon et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Bisphosphonates and Atrial Fibrillation Systematic Review and Meta-Analysis
Yoon Kong Loke et al.
DRUG SAFETY (2009)
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Michael Gnant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole
Nigel J. Bundred et al.
CANCER (2008)
Hip bone density predicts breast cancer risk independently of gail score - Results from the women's health initiative
Zhao Chen et al.
CANCER (2008)
Emerging robe of bisphosphonates in the clinic - Antitumor activity and prevention of metastasis to bone
Allan Lipton
CANCER TREATMENT REVIEWS (2008)
Pharmacotherapies to manage bone loss-associated diseases: A quest for the perfect benefit-to-risk ratio
P. Valverde
CURRENT MEDICINAL CHEMISTRY (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
M. Aapro et al.
ANNALS OF ONCOLOGY (2008)
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005
Joanna Watson et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Breast tumours following combined hormone replacement therapy express favourable prognostic factors
Signe Borgquist et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Discovery, clinical development, and therapeutic uses of bisphosphonates
AA Licata
ANNALS OF PHARMACOTHERAPY (2005)
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer
T Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Early detection of bone metastases in a murine model using fluorescent human breast cancer cells:: Application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions
O Peyruchaud et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Bone mineral density and breast cancer risk in postmenopausal women
DSM Buist et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
分享论文
